Found: 9
Select item for more details and to access through your institution.
Prognostic value of PET/CT and CT in T‐cell lymphoblastic lymphoma/leukaemia patients: A retrospective cohort study of 145 patients.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 3, p. e21, doi. 10.1111/bjh.18707
- By:
- Publication type:
- Article
HER2-overexpressing breast cancer: FDG uptake after two cycles of chemotherapy predicts the outcome of neoadjuvant treatment.
- Published in:
- British Journal of Cancer, 2013, v. 109, n. 5, p. 1157, doi. 10.1038/bjc.2013.469
- By:
- Publication type:
- Article
RISK STRATIFICATION OF DLBCL WITH MVED2 SCORE USING INTEGRATIVE HOST ADIPOSE DENSITY AND METABOLIC TUMOR CHARACTERISTICS COMPARED TO OTHER INDEXES.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 91, doi. 10.1002/hon.3163_55
- By:
- Publication type:
- Article
HIGH ADIPOSE TISSUE DENSITY IS A NEGATIVE PROGNOSTIC FACTOR IN DLBCL PATIENTS TREATED BY R‐CHOP, INDEPENDENT FROM TMTV AND PS –FROM THE REMARC STUDY.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.78_2880
- By:
- Publication type:
- Article
CIRCULATING TUMOR DNA LOAD AND TOTAL METABOLIC TUMOR VOLUME IN DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) PATIENTS TREATED BY R‐CHOP – FROM REMARC, A LYSA STUDY.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.3_2880
- By:
- Publication type:
- Article
DEFINING ULTRA‐HIGH‐RISK DLBCL PATIENTS PRIOR TO INITIAL TREATMENT BASED ON AN INTEGRATIVE HOST AND DISEASE PROGNOSTIC SCORE (FROM REMARC STUDY)
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.17_2879
- By:
- Publication type:
- Article
HIGH TOTAL METABOLIC TUMOR VOLUME AT BASELINE ALLOWS TO DISCRIMINATE FOR SURVIVAL PATIENTS IN RESPONSE AFTER R‐CHOP: AN ANCILLARY ANALYSIS OF THE REMARC STUDY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 49, doi. 10.1002/hon.19_2629
- By:
- Publication type:
- Article
HIGH TOTAL METABOLIC TUMOR VOLUME AT BASELINE ALLOWS TO DISCRIMINATE FOR SURVIVAL PATIENTS IN RESPONSE AFTER R‐CHOP: AN ANCILLARY ANALYSIS OF THE REMARC STUDY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 49, doi. 10.1002/hon.19_2629
- By:
- Publication type:
- Article
Prognostic impact of (18)FDG-PET-CT findings in clinical stage III and IIB breast cancer.
- Published in:
- 2012
- By:
- Publication type:
- journal article